
Shares of drugmaker AbbVie ABBV.N rise 1.7% to $229.07
Co says it will invest $380 mln to build two new plants in North Chicago to produce ingredients for obesity and neurological drugs, using AI technologies
Construction begins in spring 2026, with operations expected in 2029; 300 hires planned, according to co
Co says the investment is part of its $100 bln U.S. R&D and capital spending plan; it is also acquiring a site in Arizona and expanding in Massachusetts
Shares up ~29% in 2025